183 related articles for article (PubMed ID: 12449099)
21. Stage-dependent patterns of disturbed neural synchrony in Parkinson's disease.
Berendse HW; Stam CJ
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S440-5. PubMed ID: 18267280
[TBL] [Abstract][Full Text] [Related]
22. Indirect-pathway neurons lose their spines in Parkinson disease.
Gerfen CR
Nat Neurosci; 2006 Feb; 9(2):157-8. PubMed ID: 16439979
[No Abstract] [Full Text] [Related]
23. A neural network model of Parkinson's disease bradykinesia.
Cutsuridis V; Perantonis S
Neural Netw; 2006 May; 19(4):354-74. PubMed ID: 16359844
[TBL] [Abstract][Full Text] [Related]
24. Dopamine and adult neurogenesis.
Borta A; Höglinger GU
J Neurochem; 2007 Feb; 100(3):587-95. PubMed ID: 17101030
[TBL] [Abstract][Full Text] [Related]
25. Molecular and cellular alterations in the Pitx3-deficient midbrain dopaminergic system.
Smits SM; Mathon DS; Burbach JP; Ramakers GM; Smidt MP
Mol Cell Neurosci; 2005 Nov; 30(3):352-63. PubMed ID: 16140547
[TBL] [Abstract][Full Text] [Related]
26. Cellular principles underlying normal and pathological activity in the subthalamic nucleus.
Bevan MD; Atherton JF; Baufreton J
Curr Opin Neurobiol; 2006 Dec; 16(6):621-8. PubMed ID: 17084618
[TBL] [Abstract][Full Text] [Related]
27. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
28. Contributions of functional imaging to understanding parkinsonian symptoms.
Grafton ST
Curr Opin Neurobiol; 2004 Dec; 14(6):715-9. PubMed ID: 15582373
[TBL] [Abstract][Full Text] [Related]
29. Parkinson revisited: pathophysiology of motor signs.
Hallett M
Adv Neurol; 2003; 91():19-28. PubMed ID: 12442661
[No Abstract] [Full Text] [Related]
30. Imaging of compensatory mechanisms in Parkinson's disease.
Appel-Cresswell S; de la Fuente-Fernandez R; Galley S; McKeown MJ
Curr Opin Neurol; 2010 Aug; 23(4):407-12. PubMed ID: 20610991
[TBL] [Abstract][Full Text] [Related]
31. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.
González-Hernández T; Barroso-Chinea P; Rodríguez M
Mov Disord; 2004 Sep; 19(9):1029-1042. PubMed ID: 15372592
[TBL] [Abstract][Full Text] [Related]
32. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
[TBL] [Abstract][Full Text] [Related]
33. The pathology of Parkinson's disease.
Jellinger KA
Adv Neurol; 2001; 86():55-72. PubMed ID: 11554010
[No Abstract] [Full Text] [Related]
34. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
35. Dopaminergic neurons reduced to silence by oxidative stress: an early step in the death cascade in Parkinson's disease?
Michel PP; Ruberg M; Hirsch E
Sci STKE; 2006 Apr; 2006(332):pe19. PubMed ID: 16639033
[TBL] [Abstract][Full Text] [Related]
36. [Dopaminergic neurons and clinical neuropsychiatry].
Ferrari E
Acta Neurol (Napoli); 1992; 14(4-6):241-64. PubMed ID: 1293968
[TBL] [Abstract][Full Text] [Related]
37. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
38. Basal ganglia oscillations and pathophysiology of movement disorders.
Rivlin-Etzion M; Marmor O; Heimer G; Raz A; Nini A; Bergman H
Curr Opin Neurobiol; 2006 Dec; 16(6):629-37. PubMed ID: 17084615
[TBL] [Abstract][Full Text] [Related]
39. Impaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77-knockout mice.
St-Hilaire M; Bourhis E; Lévesque D; Rouillard C
Eur J Neurosci; 2006 Aug; 24(3):795-805. PubMed ID: 16930409
[TBL] [Abstract][Full Text] [Related]
40. The second brain and Parkinson's disease.
Lebouvier T; Chaumette T; Paillusson S; Duyckaerts C; Bruley des Varannes S; Neunlist M; Derkinderen P
Eur J Neurosci; 2009 Sep; 30(5):735-41. PubMed ID: 19712093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
